Litigation Details for Novo Nordisk Inc. v. Sun Pharmaceutical Industries Ltd. (D. Del. 2022)
✉ Email this page to a colleague
Novo Nordisk Inc. v. Sun Pharmaceutical Industries Ltd. (D. Del. 2022)
| Docket | ⤷ Start Trial | Date Filed | 2022-07-01 |
| Court | District Court, D. Delaware | Date Terminated | 2023-12-19 |
| Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
| Jury Demand | None | Referred To | |
| Patents | 10,220,155; 10,357,616; 10,376,652; 11,097,063; 8,114,833; 8,684,969; 8,920,383; 9,132,239; 9,457,154; 9,616,180; 9,687,611; 9,775,953; 9,861,757; 9,968,659; RE46,363 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Novo Nordisk Inc. v. Sun Pharmaceutical Industries Ltd.
Biologic Drugs cited in Novo Nordisk Inc. v. Sun Pharmaceutical Industries Ltd.
The biologic drugs covered by the patents cited in this case are ⤷ Start Trial , ⤷ Start Trial , ⤷ Start Trial , ⤷ Start Trial , ⤷ Start Trial , and ⤷ Start Trial .
Details for Novo Nordisk Inc. v. Sun Pharmaceutical Industries Ltd. (D. Del. 2022)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2022-07-01 | External link to document | |||
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
